Purpose
to perform early testing of a novel adjuvant to induce intestinal mucosal immunity with non-replicating polio vaccines
Grantee
Division
Global Development,
Global Health
Date
JUNE 2025
Region served
AFRICA,
ASIA
Committed amount
$1,699,983
Grant topic
Polio,
Vaccine Development
Duration (months)
22
Grantee location
Charlottesville, Virginia, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.